Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports

Authors: Junichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, Yong-Mei Guo, Nobue Sato, Yosuke Minami

Source: Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)

Subject Terms: Relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia, Blinatumomab, Ponatinib, Tyrosine kinase inhibitor, BCR–ABL compound mutations, Medicine

File Description: electronic resource

Relation: https://doaj.org/toc/1752-1947

Access URL: https://doaj.org/article/597cbb906d174e52b7970f3b4728ed99